Barbacid M, Contreras A, Vazquez D
Biochim Biophys Acta. 1975 Jul 7;395(3):347-54. doi: 10.1016/0005-2787(75)90206-3.
The antibiotic griseoviridin binds to the larger subunit of Escherichia coli ribosomes blocking the interaction between the 3' terminal end of peptidyl-tRNA and the donor site of the peptidyl transferase centre. Griseoviridin inhibits binding of chloramphenicol, thiamphenicol, lincomycin, erythromycin and streptogramin A to bacterial ribosomes. Moreover griseoviridin protects the ribosomal binding site of gougerotin from the drastic conformational changes taking place in the presence of ethanol. Griseoviridin is also able to interact with eukaryotic ribosomes as shown by its effects on model systems and on anisomycin, trichodermin and gougerotin binding studies. Nevertheless, griseoviridin affinity for the 80-S type ribosomes (yeast or human) is two orders of magnitude smaller than with E. coli ribosomes. The inhibitory spectrum and mode of action of griseoviridin on ribosomes is compared to that of antibiotics of the streptogramin A group and found to be essentially the same.
抗生素灰黄霉素与大肠杆菌核糖体的大亚基结合,阻断肽基 - tRNA 3'末端与肽基转移酶中心供体位点之间的相互作用。灰黄霉素抑制氯霉素、甲砜霉素、林可霉素、红霉素和链阳菌素 A 与细菌核糖体的结合。此外,灰黄霉素可保护谷氏菌素的核糖体结合位点,使其免受乙醇存在时发生的剧烈构象变化的影响。如对模型系统以及对茴香霉素、木霉菌素和谷氏菌素结合研究的影响所示,灰黄霉素也能够与真核核糖体相互作用。然而,灰黄霉素对 80 - S 型核糖体(酵母或人类)的亲和力比对大肠杆菌核糖体的亲和力小两个数量级。将灰黄霉素对核糖体的抑制谱和作用模式与链阳菌素 A 组抗生素的进行比较,发现基本相同。